Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
GPAA1	"GAA1, hGAA1"	ENSG00000197858	"Glycosylphosphatidylinositol anchor attachment 1"	O43292	8	144082590-144086216	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077224	Approved		Approved	"Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Centrosome, Mitochondria"	"HPA077224: "	"unprognostic (2.53e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.64e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	25.2	35.3	23.0	15.9	25.5	32.1	20.0	19.9	43.7	23.6	24.4	27.1	32.3	28.2	26.3	38.3	23.2	24.0	31.1	35.0	20.3	17.4	29.3	47.2	24.9	31.4	19.9	19.0	23.8	46.6	36.4	17.1	32.9	25.1	23.1	10.7	27.4	46.0	35.4	28.5	23.3	31.0	16.3	22.3	21.9	23.0	24.6	16.1	24.0	29.0	22.2	18.6	19.3	18.6	17.2	41.0	21.7	33.3	24.7	34.5	26.1	16.4	29.1	6.8	21.3	15.8	13.5	23.7	16.9	16.8	14.2	14.8	12.0	27.3	9.0	24.7	18.3	6.7	20.5	4.5	16.8	2.1	15.1	15.3	14.1	13.6	8.8	15.3	6.9	21.3	14.8	15.7	14.5	10.1	11.5	11.7	15.3	10.2	31.9	13.6	57.9	13.3	6.4	6.8	19.4	70.8	9.3	8.6	42.8	12.3	11.6	11.8	16.2	22.1	28.5	12.4	3.9	18.3	19.5	7.7	13.2	23.0	7.5	18.9	17.8	13.7	5.9	23.4	8.5	17.9	11.8	24.8	21.7	34.5	29.9	23.7	15.5	17.4	27.1	23.1	17.2	17.3	24.1	5.8	24.7	33.3	41.0	15.0	26.1	23.0	25.5	19.9	43.7	20.3	17.4	19.9	19.0	25.1	16.1	35.7	40.2	43.2	39.6	25.5	57.0	39.1	40.8	26.8	11.4	41.8	60.9	106.7	21.6	110.5	4.7	29.4	99.5	0.0	78.8	116.9	52.6	52.7	65.6	67.2	78.9	52.4	54.6	43.0	45.7	6.6	37.4	40.2	69.2	59.5	47.2	94.2	69.6	80.7	35.3	71.5	53.5	58.2	37.1	132.9	51.7	19.4	91.4	48.0	73.6	37.1
OXSM	"CEM1, FASN2D, FLJ20604, KS"	ENSG00000151093	"3-oxoacyl-ACP synthase, mitochondrial"	Q9NWU1	3	25782917-25794534	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021293, HPA021300, HPA021337"	Enhanced		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA021293: AB_1848772, HPA021300: AB_1848774, HPA021337: AB_1848776"	"unprognostic (2.20e-2)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.35e-4)"	"prognostic favorable (5.51e-4)"	"unprognostic (1.01e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.20e-1)"	"prognostic favorable (4.18e-9)"	"unprognostic (1.79e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.73e-2)"	6.2	13.7	6.7	9.8	10.5	3.7	10.3	8.3	11.9	6.0	11.8	6.2	13.7	10.1	6.4	16.2	10.3	7.7	7.9	13.5	6.6	6.4	14.9	26.1	10.0	7.7	6.6	6.5	6.4	18.7	8.3	13.0	7.3	7.0	8.0	13.8	10.4	15.5	15.6	19.4	8.3	8.9	5.8	6.7	9.6	8.9	19.9	8.0	8.1	11.7	12.3	11.3	7.9	6.4	8.4	9.0	3.7	6.5	10.3	11.8	6.6	7.7	12.9	2.7	7.6	8.0	8.8	8.0	6.2	9.0	11.7	8.3	9.8	9.3	14.3	8.4	5.7	6.8	8.2	11.4	11.9	11.0	8.6	11.5	15.8	10.9	11.8	9.8	12.7	10.1	8.2	14.8	9.3	9.8	7.6	10.0	13.6	16.2	11.6	9.9	11.5	9.3	9.8	0.5	6.2	14.9	12.4	7.2	23.4	17.1	4.8	3.9	7.2	9.9	17.0	12.6	4.6	18.6	11.9	6.1	7.3	8.8	9.6	8.9	11.1	12.8	4.5	10.3	11.2	7.5	2.1	5.4	3.7	9.4	6.0	10.8	8.4	9.7	11.6	8.6	8.2	11.4	11.8	0.9	10.3	6.5	9.0	6.0	6.6	6.7	10.5	8.3	11.9	6.6	6.4	6.6	6.5	7.0	8.0	0.0	10.3	2.9	5.0	2.7	6.2	9.8	7.6	5.3	4.5	10.4	3.9	17.5	10.0	11.3	38.3	4.9	6.3	0.0	5.9	13.9	6.5	5.4	9.3	13.9	7.7	4.8	2.4	6.7	2.7	11.5	6.6	3.7	5.0	6.4	9.8	8.3	7.4	7.6	3.9	16.1	6.5	0.0	3.1	26.1	12.0	3.9	11.8	5.0	9.6	2.4
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		18000	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: AB_2686753"	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favorable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	7.7	9.2	28.8	10.5	34.2	12.5	6.5	14.1	48.0	9.7	8.8	10.1	4.9	9.1	9.7	6.1	8.3	8.4	8.0	8.5	30.4	19.2	9.0	12.6	9.0	11.2	19.0	25.9	10.2	8.6	25.6	12.5	10.4	19.3	9.8	8.9	10.8	6.8	10.6	7.1	6.6	10.0	13.2	6.8	10.2	9.9	13.1	8.2	17.9	9.9	2.9	10.2	8.4	4.8	5.0	12.5	7.6	5.5	9.1	7.7	2.9	9.9	8.4	7.4	11.1	21.2	12.8	10.6	9.0	13.7	13.3	13.1	6.5	4.2	18.7	5.4	18.1	13.1	8.8	14.0	8.7	8.2	15.9	21.5	19.2	11.3	7.4	10.6	19.0	15.4	11.4	5.5	11.3	6.3	8.7	10.8	5.7	52.4	15.9	10.3	13.7	16.6	6.5	5.8	17.8	8.7	16.7	16.2	3.4	7.4	15.9	18.2	13.3	11.8	13.8	9.4	10.8	11.6	8.7	10.9	24.3	12.6	8.9	7.6	12.2	12.4	14.9	16.0	13.7	10.1	3.1	5.5	7.3	5.1	5.4	4.9	4.6	5.6	6.1	3.6	5.0	5.7	7.7	7.6	9.1	4.6	12.5	5.8	2.9	28.8	34.2	14.1	48.0	30.4	19.2	19.0	25.9	19.3	8.2	11.9	25.4	14.0	5.7	9.0	32.8	25.7	25.5	6.7	9.1	7.0	45.2	15.6	1.7	8.5	30.2	12.8	18.2	0.0	5.5	16.0	10.8	10.3	11.5	15.5	17.4	35.0	18.4	14.7	15.5	19.2	18.4	16.5	10.1	6.4	16.8	22.8	7.1	10.5	22.6	9.1	23.8	25.8	10.5	32.1	28.9	8.5	16.7	13.3	12.7	7.0
PI4KB	"PI4K-BETA, pi4K92, PIK4CB"	ENSG00000143393	"Phosphatidylinositol 4-kinase beta"	Q9UBF8	1	151291797-151327715	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006280, HPA006281, CAB022071"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.23e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (8.51e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (7.08e-2)"	25.5	22.2	29.8	21.6	32.3	41.6	27.3	42.6	47.2	30.8	27.1	44.8	26.6	21.8	38.6	35.8	25.6	33.0	25.1	23.8	26.3	22.5	25.6	19.3	27.2	26.2	38.7	28.8	38.6	22.6	41.8	35.5	24.2	29.6	32.2	28.1	28.8	27.1	29.9	36.2	36.9	25.3	39.8	22.7	34.7	23.7	33.1	34.0	26.2	41.2	24.6	28.7	27.1	30.1	17.1	19.7	27.9	20.4	14.7	20.3	17.1	19.7	16.5	14.4	22.5	40.0	29.6	12.2	21.0	36.7	27.5	22.9	21.0	18.0	18.7	24.2	32.1	17.4	18.6	23.8	21.6	21.3	25.3	21.1	13.3	19.6	10.8	28.0	15.3	25.8	30.9	26.3	30.4	21.8	23.9	26.5	19.2	22.8	28.4	23.3	36.7	16.2	12.4	11.5	28.2	25.1	14.6	12.1	21.9	19.0	25.1	17.4	15.0	14.6	29.8	18.8	23.8	25.1	29.2	20.6	19.8	15.6	15.7	22.3	30.2	19.6	36.4	22.5	16.1	34.2	25.2	17.5	27.9	15.6	20.4	17.4	17.1	16.1	20.3	19.7	15.1	13.6	12.5	17.2	14.7	19.6	11.4	15.9	17.1	29.8	32.3	42.6	47.2	26.3	22.5	38.7	28.8	29.6	34.0	14.9	25.3	16.7	17.9	19.8	30.2	6.7	20.4	9.4	14.8	12.2	19.6	22.5	16.6	17.6	8.9	15.8	24.9	0.0	21.6	16.5	23.4	16.5	18.5	10.9	24.5	33.4	17.7	9.8	15.9	11.5	21.6	17.4	13.5	31.5	17.8	18.9	18.2	17.5	23.3	12.4	26.6	12.9	23.7	24.7	23.0	27.1	40.7	21.0	18.0	26.9
PIGF		ENSG00000151665	"Phosphatidylinositol glycan anchor biosynthesis class F"	Q07326	2	46580937-46617119	"Predicted membrane proteins"	"GPI-anchor biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051389	Uncertain					NA	NA					"HPA051389: AB_2681464"	"unprognostic (3.85e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.18e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.52e-3)"	"prognostic unfavorable (1.39e-5)"	"unprognostic (4.97e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.71e-2)"	14.4	30.9	18.5	13.9	19.3	6.9	17.7	13.6	17.9	14.0	17.3	19.0	19.6	16.3	20.1	29.4	17.1	15.3	14.8	12.4	16.6	19.4	20.8	15.9	13.6	11.8	20.6	12.8	13.2	21.0	17.7	37.8	15.5	21.5	14.9	19.8	14.9	28.6	13.4	16.4	11.4	16.5	8.3	25.4	15.2	14.9	25.0	23.0	11.0	25.8	15.3	14.7	18.4	13.5	13.6	17.8	9.2	15.9	9.5	13.2	6.0	13.9	8.1	17.7	9.1	22.6	24.5	10.9	15.3	10.7	7.2	7.4	4.0	10.4	7.1	31.0	11.2	15.5	11.2	16.5	12.6	14.6	23.6	17.4	16.3	6.3	22.0	13.0	10.0	11.7	16.8	19.0	10.9	16.0	21.3	19.5	7.5	14.5	19.6	26.6	3.5	7.8	9.5	14.0	28.6	13.4	7.9	14.8	17.5	20.9	13.9	12.1	13.9	7.3	10.5	18.4	14.7	5.8	11.1	11.7	9.0	10.3	13.5	15.4	9.4	12.4	12.3	9.3	18.6	19.6	3.0	12.3	9.2	9.8	15.9	10.1	11.1	11.3	9.3	12.9	13.6	8.8	11.1	5.3	9.5	15.0	17.8	13.2	6.0	18.5	19.3	13.6	17.9	16.6	19.4	20.6	12.8	21.5	23.0	8.9	14.4	18.2	34.3	22.7	30.1	2.8	25.5	20.1	23.9	19.2	27.5	33.3	29.9	22.6	50.0	27.0	15.7	0.0	26.5	45.0	20.9	34.7	18.5	22.6	33.3	35.0	16.7	20.9	22.9	18.6	13.8	20.0	28.7	22.6	26.6	50.6	20.3	28.1	15.2	27.1	24.7	6.5	15.5	84.4	41.1	29.7	27.0	14.4	32.9	38.3
PIGG	"FLJ20265, GPI7, LAS21"	ENSG00000174227	"Phosphatidylinositol glycan anchor biosynthesis class G"	Q5H8A4	4	499210-540196	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015997	Uncertain					NA	NA					"HPA015997: AB_2164679"	"unprognostic (3.87e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.48e-2)"	"unprognostic (4.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.01e-3)"	"unprognostic (6.61e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.97e-2)"	16.2	22.0	12.8	19.8	19.7	11.3	17.1	21.3	23.2	13.3	15.6	23.2	21.5	18.8	23.2	28.7	16.7	15.6	17.4	11.5	13.6	12.5	15.5	13.0	15.5	16.5	20.3	16.0	22.1	18.6	31.1	22.9	16.7	17.2	16.9	16.5	19.5	20.9	19.1	10.7	26.6	17.5	19.3	21.8	17.7	17.5	19.9	17.6	16.2	21.9	9.6	15.1	19.5	15.0	4.2	9.2	16.4	7.5	8.1	9.0	4.5	10.7	12.0	10.9	9.2	20.0	14.4	17.2	14.3	17.2	15.4	18.2	12.2	25.6	4.4	10.4	18.0	28.0	14.4	10.3	14.0	14.1	4.2	11.1	11.2	14.6	9.5	14.0	15.4	16.9	16.1	23.4	14.1	7.8	16.6	11.6	8.9	12.3	10.3	13.6	6.6	8.6	13.3	17.4	11.7	16.4	9.5	6.7	6.7	14.5	14.9	10.9	13.9	10.4	10.8	9.9	10.8	17.4	13.9	17.8	15.9	7.4	7.8	22.1	8.3	10.8	7.1	13.5	11.4	19.5	16.4	5.9	4.7	7.2	7.5	8.3	4.2	5.7	6.9	9.2	3.6	6.2	5.0	4.3	8.1	5.3	8.0	9.0	4.5	12.8	19.7	21.3	23.2	13.6	12.5	20.3	16.0	17.2	17.6	14.9	9.3	5.1	8.9	7.9	10.4	6.5	2.5	14.7	18.2	8.7	3.9	14.4	0.0	14.3	1.6	10.3	12.4	0.0	15.6	12.3	8.1	11.6	12.7	8.3	8.2	7.9	10.4	6.7	11.6	0.4	12.7	10.7	8.5	13.6	7.5	15.1	14.5	10.1	12.0	5.7	10.3	19.4	6.2	9.7	9.3	5.5	19.3	10.0	8.6	12.2
PIGK	"GPI8, hGPI8"	ENSG00000142892	"Phosphatidylinositol glycan anchor biosynthesis class K"	Q92643	1	77088990-77219430	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056383, HPA057040"	Uncertain				"Intracellular and membrane"	NA	NA					"HPA056383: AB_2683109, HPA057040: AB_2683319"	"unprognostic (2.43e-2)"	"unprognostic (2.60e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (4.68e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.19e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.12e-3)"	14.5	17.4	13.8	8.0	20.4	10.2	17.1	14.8	22.9	14.2	11.4	17.4	9.6	9.2	14.6	13.8	10.7	13.0	13.6	20.0	15.4	17.7	25.4	19.0	12.3	10.6	17.7	11.7	13.7	14.1	24.9	23.1	11.2	23.8	15.9	12.9	11.2	11.9	12.9	11.9	7.6	11.6	14.5	19.9	14.7	11.6	9.6	17.2	14.6	22.3	8.1	9.8	12.9	9.4	5.2	7.6	7.6	4.4	8.9	12.8	6.3	5.7	6.8	5.6	7.1	32.4	24.4	9.1	11.7	16.1	12.3	17.7	5.6	5.9	5.0	12.1	20.7	14.7	5.2	7.1	10.0	22.5	10.4	7.3	6.8	7.3	5.2	7.2	15.1	6.1	14.7	5.4	13.1	11.4	14.8	18.1	6.3	8.3	17.4	18.9	3.9	4.7	6.1	5.0	6.5	11.3	5.6	16.5	6.4	15.7	4.2	4.8	4.5	11.1	10.1	12.7	9.7	4.8	8.7	10.3	19.9	7.8	10.7	11.9	7.9	11.0	5.1	14.8	19.2	7.8	6.9	4.1	7.6	8.3	4.4	8.4	5.2	8.5	7.0	7.6	4.1	10.7	9.5	2.0	8.9	4.2	5.2	12.8	6.3	13.8	20.4	14.8	22.9	15.4	17.7	17.7	11.7	23.8	17.2	8.9	7.8	11.5	13.1	8.5	13.1	18.9	22.9	20.1	9.1	38.4	2.0	16.1	3.3	18.9	1.5	17.3	6.5	0.0	18.7	28.7	19.2	13.7	17.3	24.6	18.1	7.9	10.4	16.5	14.3	2.2	18.1	11.1	18.6	8.2	11.9	15.7	11.7	7.0	25.8	18.8	7.2	51.8	21.2	56.1	20.2	10.5	12.7	18.1	11.2	10.8
PIGS		ENSG00000087111	"Phosphatidylinositol glycan anchor biosynthesis class S"	Q96S52	17	28553383-28571872	"Plasma proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018149	Approved					NA	NA					"HPA018149: AB_1855373"	"unprognostic (2.29e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.82e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.65e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (5.31e-4)"	13.2	11.6	10.9	8.3	15.3	13.7	11.3	22.0	18.3	9.7	16.0	13.7	9.6	16.4	12.6	11.4	19.0	13.6	12.8	20.2	10.0	9.1	18.8	6.3	11.5	15.4	9.7	12.9	11.3	17.3	17.0	9.1	10.9	14.0	11.5	9.9	16.8	12.0	11.3	21.0	14.9	23.6	11.0	10.1	13.7	15.5	14.9	9.0	14.9	17.6	9.4	12.2	12.7	11.9	6.2	16.4	14.4	13.0	8.0	7.7	7.9	5.9	14.2	3.1	10.0	7.1	7.0	9.3	5.6	6.1	7.5	10.6	14.0	3.8	4.8	8.5	7.6	5.1	8.4	5.9	7.3	2.6	12.2	34.0	7.4	10.8	4.9	8.1	10.6	13.7	7.4	5.5	3.5	5.0	4.4	12.0	5.0	21.4	4.6	6.1	11.0	6.6	7.5	2.5	7.1	5.5	4.6	18.4	9.6	4.5	7.6	14.0	9.2	9.9	16.3	7.1	3.7	13.1	8.0	10.4	3.8	5.1	5.7	6.8	6.3	11.0	3.8	6.1	10.3	6.2	9.3	13.0	14.4	7.6	11.4	6.9	6.2	4.8	7.2	16.4	4.5	6.5	4.7	4.3	8.0	7.9	10.8	7.7	7.9	10.9	15.3	22.0	18.3	10.0	9.1	9.7	12.9	14.0	9.0	41.7	18.4	9.7	9.7	7.3	20.7	36.9	5.1	12.0	10.3	43.6	60.9	29.9	10.0	37.2	6.9	14.6	37.0	0.0	23.0	45.5	9.9	13.2	3.5	5.9	27.0	49.3	39.1	27.0	27.5	9.7	22.2	19.1	6.8	25.2	27.9	15.8	17.5	11.5	21.2	16.5	54.5	6.5	12.3	46.2	44.5	10.9	30.4	21.8	24.2	9.7
PIGU	"bA346K17.2, CDC91L1, GAB1"	ENSG00000101464	"Phosphatidylinositol glycan anchor biosynthesis class U"	Q9H490	20	34560542-34698790	"Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041706, HPA046766"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041706: AB_2677627, HPA046766: AB_2679794"	"unprognostic (1.87e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-3)"	"unprognostic (7.94e-3)"	"unprognostic (2.69e-1)"	"unprognostic (9.86e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.27e-2)"	"unprognostic (4.21e-3)"	16.8	17.6	18.9	12.9	23.6	10.0	15.2	15.7	26.5	14.7	21.5	43.0	10.8	13.3	21.8	22.8	20.0	28.2	12.7	17.4	21.4	20.2	18.4	16.3	11.3	11.6	21.5	11.9	23.9	16.2	34.4	21.7	17.3	26.9	14.1	24.9	20.1	17.9	15.9	16.4	14.0	14.2	19.6	30.5	11.1	11.5	22.1	18.1	16.5	14.7	15.9	19.5	14.2	15.0	10.0	10.8	9.4	6.3	12.1	15.0	6.7	11.7	15.0	19.1	14.0	12.6	15.2	19.2	12.1	14.5	20.6	18.2	27.7	25.1	15.2	19.8	11.9	26.4	22.0	17.4	22.9	21.0	6.2	9.4	34.2	9.9	31.1	11.7	20.8	8.2	13.4	14.8	11.8	13.5	9.5	14.8	15.0	17.1	13.5	17.4	13.2	17.6	21.2	9.6	26.8	22.7	12.8	24.0	24.3	18.2	11.0	12.3	11.6	22.7	41.2	14.8	11.2	22.7	14.7	8.7	33.9	12.1	18.3	12.1	9.1	12.7	10.1	20.7	21.8	14.6	9.4	4.4	1.9	13.4	6.3	12.2	9.2	12.4	15.0	10.8	10.0	12.7	12.5	0.9	12.1	5.3	10.6	11.2	6.7	18.9	23.6	15.7	26.5	21.4	20.2	21.5	11.9	26.9	18.1	8.9	3.7	1.5	11.9	3.9	8.5	5.2	12.7	26.8	9.1	10.4	15.7	33.8	1.7	16.1	13.6	5.0	10.3	0.0	15.2	23.8	8.0	10.0	8.1	6.7	13.7	1.6	9.8	8.6	5.6	11.0	5.2	3.5	1.7	6.4	13.8	8.1	9.8	21.0	7.4	8.4	9.5	19.4	12.0	31.9	12.2	5.1	17.7	7.0	22.1	7.6
PIGZ	"FLJ12768, MGC52163, SMP3"	ENSG00000119227	"Phosphatidylinositol glycan anchor biosynthesis class Z"	Q86VD9	3	196946343-196969060	"Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.5"	"Group enriched"	"Detected in many"	4	"Enterocytes: 66.9;Mucus-secreting cells: 56.2;Paneth cells: 75.0;Undifferentiated cells: 35.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058599, HPA059920"	Approved					NA	NA					"HPA058599: AB_2683771, HPA059920: AB_2684162"	"unprognostic (1.46e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.25e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.02e-3)"	6.6	3.1	5.7	5.3	8.6	1.9	3.4	18.5	16.3	3.3	26.5	3.2	2.0	2.9	2.3	1.7	3.2	2.8	4.5	6.4	5.3	7.5	1.6	1.6	3.1	2.0	4.4	6.4	0.8	5.9	2.7	2.9	2.1	10.8	4.6	24.5	4.3	4.7	4.6	10.0	4.5	7.4	5.3	2.8	1.8	3.1	1.4	3.0	3.2	1.7	2.8	2.1	9.9	2.9	0.1	1.6	1.4	3.3	0.0	0.2	0.3	2.0	1.4	0.8	3.3	9.3	4.5	0.9	3.0	8.6	2.3	1.9	1.9	1.7	0.3	6.1	6.8	1.6	3.5	0.2	0.4	0.6	0.6	0.4	0.9	0.7	7.4	4.4	0.0	3.4	4.5	6.6	0.3	1.1	2.6	2.9	5.5	0.2	2.6	2.3	3.6	0.3	1.7	0.1	2.5	1.1	0.5	0.1	0.6	3.6	3.8	1.3	1.5	4.3	0.4	1.6	0.4	8.5	3.0	7.0	1.9	0.5	5.5	1.0	1.2	0.2	0.1	0.4	1.2	0.7	0.0	1.1	0.8	0.2	3.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	1.4	0.0	1.4	0.3	0.0	0.3	5.7	8.6	18.5	16.3	5.3	7.5	4.4	6.4	10.8	3.0	0.0	0.6	3.7	8.0	6.9	6.1	6.5	2.5	1.4	1.2	8.7	2.0	0.0	5.0	1.9	1.7	4.4	66.9	0.0	3.2	0.0	2.3	9.3	5.7	7.3	1.7	14.3	13.3	12.3	4.9	3.1	3.7	1.1	8.5	2.8	56.2	1.5	2.8	75.0	6.0	2.1	6.9	0.0	8.5	0.5	0.1	4.4	0.1	1.9	35.8	10.1
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.3	16.8	17.6	17.2	26.3	9.2	20.0	22.6	17.2	22.1	17.2	13.9	22.2	15.6	20.3	19.2	16.8	18.2	20.2	16.3	14.5	11.6	25.7	16.3	22.2	11.3	17.6	16.1	17.6	14.2	62.9	23.0	23.5	28.5	18.7	14.3	15.2	15.6	27.5	15.4	13.1	17.9	19.5	31.8	17.5	18.3	19.4	18.0	11.4	32.2	9.3	11.5	23.1	20.5	4.4	5.2	6.0	7.2	4.2	4.8	1.6	23.1	10.6	17.8	11.1	12.9	13.2	16.0	14.7	15.9	10.8	15.1	25.8	2.6	6.8	7.3	12.6	17.7	15.4	14.2	11.2	19.2	5.8	12.3	4.2	12.9	10.1	14.1	5.2	6.7	10.2	7.9	10.6	20.9	10.1	25.6	4.3	9.9	6.6	8.3	7.1	2.8	3.3	10.1	13.0	8.2	2.9	18.5	4.7	13.4	20.6	10.5	9.3	22.3	9.6	10.3	15.6	5.7	5.3	31.9	8.7	12.6	22.5	8.9	2.7	5.9	5.6	10.4	4.9	10.0	4.1	4.1	2.9	4.6	2.5	3.0	3.6	3.7	3.6	5.2	4.4	4.8	2.8	6.0	4.2	7.2	3.7	2.3	1.6	17.6	26.3	22.6	17.2	14.5	11.6	17.6	16.1	28.5	18.0	71.5	56.0	17.6	19.9	31.4	47.8	22.4	22.9	29.4	39.8	34.9	66.8	25.6	16.6	15.8	21.3	80.2	17.1	0.0	21.6	14.0	19.7	34.1	30.2	28.6	16.4	33.4	27.5	108.1	38.5	12.0	23.9	23.8	18.6	11.8	20.1	82.7	22.6	11.5	29.4	17.0	41.1	38.8	29.8	36.4	15.5	29.6	120.0	19.2	17.2	27.3
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 32.3;Ito cells: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.3;RT4: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: AB_2681104"	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.16e-4)"	12.9	4.5	11.0	16.0	19.3	5.3	11.0	9.1	17.5	7.4	17.0	36.0	9.6	15.5	10.5	5.8	14.6	7.7	14.7	10.7	14.4	9.1	7.6	5.8	18.0	23.9	24.2	11.2	3.9	6.1	4.7	4.3	20.4	14.5	7.3	14.5	6.3	8.0	14.1	20.0	22.6	15.7	11.2	16.2	14.2	20.7	2.4	23.0	31.8	9.8	8.1	23.1	13.1	11.8	7.4	0.3	0.5	0.2	1.6	2.0	0.4	3.2	6.6	5.9	5.4	3.5	0.3	32.3	0.4	1.3	1.3	0.9	3.9	8.7	5.6	1.2	0.7	1.1	8.2	3.5	2.3	0.5	3.4	0.9	0.1	13.1	1.4	0.2	1.9	4.3	0.4	2.5	0.3	0.2	0.5	8.6	5.7	2.0	3.8	0.1	7.3	6.7	5.6	5.4	12.9	4.2	7.3	1.5	1.0	1.6	33.8	6.5	3.6	11.7	16.4	3.8	2.2	7.3	1.0	0.3	0.2	2.1	0.6	0.1	4.1	1.1	7.3	0.2	3.0	0.8	0.1	0.2	0.0	1.2	0.0	1.0	2.9	1.3	0.8	0.3	7.4	0.7	0.6	0.5	1.6	0.0	0.1	2.0	0.4	11.0	19.3	9.1	17.5	14.4	9.1	24.2	11.2	14.5	23.0	0.0	12.6	11.1	1.9	3.4	16.6	6.4	0.0	2.7	4.5	3.5	0.0	3.8	0.0	1.1	0.6	20.0	14.8	0.0	3.0	3.4	4.1	2.2	32.3	3.9	3.3	14.3	9.2	27.0	2.2	0.0	1.1	2.3	3.3	2.8	23.7	2.5	3.3	10.5	7.1	1.9	1.0	0.0	3.1	0.0	1.5	6.9	1.8	2.5	13.2	6.3
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18247614-18648416	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Chemotaxis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 54.2;epididymis: 30.7;seminal vesicle: 46.0"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 15.5;Cholangiocytes: 33.1;Collecting duct cells: 38.4;Hepatocytes: 21.5;Suprabasal keratinocytes: 18.7"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 2.9;HaCaT: 4.7;hTERT-HME1: 8.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.3	0.6	0.2	0.1	0.2	0.0	6.7	0.2	0.3	0.6	0.3	0.1	54.2	0.0	0.3	30.7	4.2	0.6	6.0	0.2	0.3	0.2	9.6	8.8	0.3	0.1	0.3	0.1	0.3	1.2	8.1	0.4	1.2	0.1	2.4	0.0	0.1	13.1	46.0	0.2	7.0	2.2	0.2	0.3	0.2	15.1	2.1	0.1	0.1	0.5	1.6	0.5	0.9	0.9	0.1	0.1	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	4.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.1	8.7	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.0	6.7	15.5	0.0	0.3	33.1	0.0	1.2	38.4	0.0	1.0	1.7	1.3	3.5	0.1	0.7	0.0	0.0	4.1	0.2	0.5	0.0	21.5	0.2	0.0	0.0	0.0	1.0	1.8	0.0	0.0	1.7	0.0	0.1	0.0	0.6	0.3	0.0	1.1	0.0	0.0	0.0	2.4	2.1	18.7	0.7	0.0	0.2	0.7
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534849-22714555	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 92.0"	"Cell type enhanced"	"Detected in all"	7	"Erythroid cells: 93.5;Melanocytes: 99.5;T-cells: 152.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		8800000	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: AB_2685490, HPA068771: AB_2686030"	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	13.0	7.3	43.8	20.3	63.8	17.3	6.9	6.6	41.4	13.2	7.8	75.5	1.0	5.9	9.9	5.6	9.2	7.2	15.1	5.9	56.0	31.7	7.6	8.3	11.5	33.4	65.7	22.9	4.3	4.9	29.5	4.2	10.5	36.5	4.4	9.0	5.7	3.9	6.3	2.6	4.0	8.1	14.4	92.0	26.6	8.4	5.4	59.8	10.1	5.9	1.0	38.5	11.5	5.8	14.7	12.0	26.3	16.6	38.4	46.7	39.3	8.9	8.8	10.3	3.3	16.5	22.5	7.8	16.6	17.7	9.0	11.1	8.2	14.3	18.7	6.0	33.3	19.8	3.1	8.9	4.6	9.1	41.4	9.3	35.2	6.4	18.1	29.3	6.7	27.6	11.2	4.2	12.2	11.9	13.9	13.3	25.3	19.5	36.6	16.6	3.7	26.9	6.0	4.2	4.3	6.3	10.9	14.7	25.4	13.3	1.7	1.8	4.3	5.3	2.7	26.4	12.2	2.3	11.7	16.0	7.0	10.2	12.8	10.1	23.3	13.1	13.6	18.9	20.5	5.3	16.1	8.8	26.3	34.5	15.6	46.7	14.7	27.5	40.0	11.6	8.6	18.6	34.9	10.9	38.4	16.6	12.0	19.6	39.3	43.8	63.8	6.6	30.3	56.0	31.7	65.7	22.9	36.5	59.8	3.0	7.9	43.2	3.6	15.7	4.1	6.8	15.3	1.4	7.9	17.4	2.0	6.7	10.0	8.7	15.7	24.8	2.6	93.5	9.3	4.0	17.1	5.4	22.0	6.4	27.8	12.7	4.7	68.2	77.2	23.8	15.5	49.0	99.5	85.6	2.8	4.0	16.5	3.5	9.6	9.8	8.1	19.4	21.1	4.1	2.3	14.8	10.4	152.2	2.3	5.5
PIP4K2B	"PIP5K2B, PIP5KIIB, PIP5KIIbeta"	ENSG00000276293	"Phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	P78356	17	38765689-38800126	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 23.6"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 41.3"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062220			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062220: AB_2684715"	"unprognostic (7.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.79e-1)"	"unprognostic (4.82e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.48e-1)"	5.1	6.5	12.4	3.3	12.9	1.1	5.0	8.8	17.4	6.8	2.7	7.0	4.2	2.2	7.2	5.9	3.5	7.4	3.6	7.1	9.6		4.1	2.2	5.0	4.2	5.4	13.3	13.3	3.0	5.1	2.7	5.4	7.5	5.1	3.2	4.1	3.8	6.5	23.6	5.8	2.3	7.3	4.7	5.1	2.5	2.8	6.5	2.0	4.7	2.2	4.5	3.7	5.9	3.3	3.1	2.4	2.4	3.4	5.0	3.7	5.7	12.7	21.2	22.0	18.5	14.7	4.3	10.8	12.0	13.6	11.2	8.6	5.7	14.8	6.8	18.4	11.9	12.4	14.0	8.9	13.1	10.2	9.0	12.8	8.2	12.6	8.4	14.6	7.9	12.9	10.9	10.6	7.9	19.2	11.3	15.4	11.2	7.0	14.6	4.3	13.4	10.7	11.8	6.4	5.9	14.6	20.9	8.1	10.0	7.2	11.8	17.1	10.9	4.4	11.0	23.1	14.0	13.8	11.9	11.5	7.6	9.9	9.3	9.2	11.5	6.7	13.7	11.6	10.4	1.6	2.4	0.8	4.8	2.2	5.0	3.1	4.1	4.6	3.1	3.3	4.7	4.2	2.4	3.4	1.8	3.0	3.9	3.7											17.9	10.7	3.7	3.7	5.5	33.8	18.9	7.6	4.0	9.1	5.2	9.8	6.3	1.7	4.7	8.7	14.6	3.9	0.0	4.2	4.1	8.5	4.5	1.1	9.8	7.5	41.3	11.1	20.3	8.3	13.7	14.1	5.7	1.7	1.8	6.9	12.9	5.4	3.5	15.6	6.7	13.4	6.5	7.2	4.6	8.1	3.9	2.1	7.2	7.3	1.8
PIP4K2C	"FLJ22055, PIP5K2C"	ENSG00000166908	"Phosphatidylinositol-5-phosphate 4-kinase type 2 gamma"	Q8TBX8	12	57591174-57603418	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028658	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA028658: AB_10601245"	"unprognostic (7.84e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (7.98e-4)"	"unprognostic (3.17e-2)"	"unprognostic (6.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.06e-6)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.42e-1)"	9.3	13.3	13.9	9.2	25.9	16.7	15.0	18.9	45.5	12.5	17.5	14.6	15.8	11.6	14.2	62.0	20.0	20.0	12.1	10.8	15.4	10.9	26.9	14.4	14.4	9.2	14.3	21.2	12.3	14.9	29.6	13.7	11.1	18.8	16.7	19.4	17.4	18.6	14.6	9.4	18.4	13.3	11.9	12.7	10.7	27.6	25.6	12.1	5.9	17.9	8.5	13.1	14.6	14.1	6.8	5.4	29.7	8.4	9.4	16.1	6.5	19.1	13.5	5.5	6.6	0.0	0.0	17.8	8.0	15.0	14.5	13.5	17.2	27.7	4.1	17.6	9.3	17.9	17.5	9.0	15.7	11.7	6.2	10.1	7.5	6.5	12.1	12.8	6.9	13.5	5.0	26.7	5.5	10.3	17.8	7.3	4.6	9.6	12.6	7.5	18.9	6.2	6.0	10.5	11.7	11.8	0.1	49.9	6.2	15.2	32.8	9.3	11.5	17.2	11.5	10.9	19.4	31.6	6.4	1.6	7.3	10.1	10.7	8.4	9.7	11.3	9.3	14.4	5.9	12.1	29.7	5.2	15.3	16.1	6.2	10.7	5.9	9.9	12.0	5.4	6.8	9.6	11.5	10.2	9.4	8.4	2.3	12.1	6.5	13.9	25.9	18.9	45.5	15.4	10.9	14.3	21.2	18.8	12.1	8.9	7.5	3.0	5.7	11.0	13.1	112.2	15.3	13.4	9.1	33.2	17.7	9.3	18.3	16.2	23.8	3.5	18.0	0.0	17.1	13.6	4.9	9.9	3.5	11.6	7.9	7.9	21.4	9.8	2.9	35.3	6.4	4.1	11.8	8.2	16.1	6.5	28.1	13.6	4.9	10.1	8.3	19.4	6.4	11.9	7.1	11.2	14.5	8.7	8.6	7.1
PIP5K1A		ENSG00000143398	"Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	Q99755	1	151197949-151249536	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029366	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029366: AB_10602116"	"unprognostic (1.05e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.16e-7)"	"unprognostic (1.44e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.59e-1)"	18.1	19.5	15.7	15.4	21.0	9.6	20.2	22.6	27.6	19.8	18.0	20.3	14.7	16.4	24.8	22.6	20.7	19.4	20.7	18.9	17.3	13.4	17.8	18.3	21.7	17.1	12.7	17.5	20.4	16.6	21.8	25.3	44.6	14.6	17.3	15.6	29.5	17.8	15.2	26.1	20.4	20.4	27.2	16.1	20.1	16.8	42.1	14.0	19.3	20.1	13.9	22.3	16.2	17.7	9.1	8.7	11.7	6.2	4.7	5.9	6.3	17.7	13.8	21.4	24.7	14.1	15.0	21.1	23.5	33.0	43.9	39.4	25.1	17.2	16.2	25.0	25.0	19.8	15.1	27.7	16.1	38.5	24.3	19.8	12.8	18.3	12.0	26.7	22.9	16.2	19.9	15.0	27.3	34.6	19.4	17.8	25.8	12.5	13.8	22.0	24.9	22.8	11.4	31.7	13.6	21.5	22.1	18.7	12.0	22.5	10.3	14.4	19.0	31.7	24.4	20.6	37.4	25.6	21.7	17.1	17.5	24.4	16.1	28.2	19.3	32.1	36.5	17.0	6.7	20.8	0.1	5.5	7.3	5.3	6.2	4.1	9.1	5.0	5.9	8.4	4.6	5.4	4.2	11.7	4.7	4.8	8.7	3.9	6.3	15.7	21.0	22.6	27.6	17.3	13.4	12.7	17.5	14.6	14.0	29.8	13.5	19.0	21.3	58.7	33.2	17.3	12.7	12.0	11.4	29.6	92.3	21.0	8.3	11.8	2.8	13.2	15.9	0.0	7.5	24.0	19.1	15.9	11.5	11.6	11.1	25.4	5.8	17.8	10.1	3.6	12.4	11.5	11.8	10.0	8.4	13.8	13.3	8.4	10.3	7.9	43.5	12.9	19.6	46.5	22.4	43.7	53.1	8.7	9.5	32.5
PIP5K1B	"MSS4, STM7"	ENSG00000107242	"Phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	O14986	9	68705414-69009176	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 103.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 22.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 22.1"	"Cell line enhanced"	"Detected in some"		"AF22: 23.8;HEL: 8.9;Hep G2: 7.3;OE19: 39.1;U-266/70: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009687	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA009687: AB_1855391"	"unprognostic (2.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.85e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.03e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	4.0	9.5	9.4	8.4	6.5	10.2	4.2	33.4	14.6	5.6	26.9	4.1	10.8	26.1	6.1	2.0	1.2	5.0	7.6	24.6	8.1	11.7	6.1	0.8	12.6	2.1	10.4	6.4	1.4	6.7	21.3	8.5	16.8	32.8	3.3	23.1	28.7	11.6	13.6	3.0	2.4	39.7	2.6	3.7	3.1	19.9	17.6	1.5	0.0	1.6	1.9	3.3	3.5	2.9	3.9	0.9	22.1	0.3	0.0	1.0	0.2	0.0	0.0	23.8	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	8.9	0.2	7.3	0.0	0.5	2.2	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.4	5.1	0.1	0.6	0.0	0.1	1.2	39.1	0.7	0.7	0.0	0.1	0.1	1.8	0.4	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	9.2	1.7	1.1	0.0	1.6	0.0	3.1	0.3	22.1	0.0	0.0	0.0	3.3	0.2	0.0	0.1	3.9	0.5	0.0	1.2	0.0	0.1	0.9	1.0	0.2	9.4	6.5	33.4	14.6	8.1	11.7	10.4	6.4	32.8	1.5	32.8	27.2	5.2	3.0	0.6	4.6	51.2	5.1	4.0	2.3	5.2	2.0	16.1	23.2	1.3	54.3	3.0	49.9	46.7	12.3	0.7	1.0	2.3	5.7	0.0	3.2	0.0	35.5	1.8	1.3	32.7	2.3	2.2	5.0	0.0	26.7	103.2	5.6	33.1	1.4	0.7	3.1	25.8	46.7	1.2	1.7	0.3	7.3	1.3	23.7	4.3
PIP5K1C	"KIAA0589, LCCS3, PIP5Kgamma"	ENSG00000186111	"Phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	O60331	19	3630183-3700479	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Endocytosis, Exocytosis, Phagocytosis"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017168	Approved		Approved	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"HPA017168: AB_1855395"	"unprognostic (1.20e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.36e-3)"	"prognostic favorable (7.28e-5)"	"unprognostic (7.03e-2)"	"unprognostic (4.02e-3)"	"unprognostic (5.80e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.57e-3)"	"prognostic favorable (2.32e-4)"	"unprognostic (1.51e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	16.1	10.2	20.5	12.8	25.8	4.5	8.0	58.6	46.3	10.7	23.5	8.5	14.8	10.9	19.8	10.0	12.3	12.8	12.7	13.8	22.8	10.7	7.5	3.8	11.5	7.5	11.3	17.1	11.5	17.2	10.0	9.2	13.7	19.0	16.7	6.4	16.9	20.0	33.4	13.5	10.2	11.5	19.2	6.3	15.8	13.6	23.9	8.7	5.3	9.3	3.9	6.0	17.3	19.0	2.5	3.2	3.6	3.0	1.7	2.8	2.0	9.2	8.8	6.9	8.9	13.5	11.0	10.4	17.9	11.3	7.7	6.2	7.8	2.6	3.9	6.9	19.1	8.5	8.2	3.2	5.8	3.2	13.8	5.8	4.4	7.3	6.3	11.3	4.5	13.8	12.2	5.5	6.3	2.4	5.5	13.0	5.9	6.7	7.2	7.2	7.7	5.4	3.3	7.2	3.4	12.2	10.2	5.3	5.3	5.7	8.0	7.0	6.0	9.2	5.0	5.4	9.0	4.0	6.8	28.6	10.8	6.2	38.1	8.3	8.3	6.6	1.7	14.5	9.5	7.7	3.6	2.8	0.0	2.8	2.6	1.2	2.5	2.1	2.0	3.2	1.3	1.0	1.6	2.2	1.7	3.0	2.2	1.4	2.0	20.5	25.8	58.6	46.3	22.8	10.7	11.3	17.1	19.0	8.7	6.0	5.3	5.4	2.8	4.7	40.8	5.5	7.6	2.7	0.0	15.7	35.3	6.2	1.7	6.9	8.4	12.0	7.0	0.0	6.2	6.0	8.5	4.9	1.1	3.6	13.3	28.6	8.1	16.0	11.0	17.7	13.8	10.8	5.0	13.6	9.2	10.5	9.9	7.0	22.6	5.7	26.6	12.9	10.7	19.0	10.4	5.9	13.7	6.4	5.7	3.8
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600405-171810950	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 52.1"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 50.9;Proximal tubular cells: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 30.3;SK-MEL-30: 16.9;TIME: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004527, HPA042396"	Enhanced					NA	NA					"CAB004527: AB_677324, HPA042396: AB_2677977"	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.76e-6)"	7.0	26.6	5.3	6.1	20.4	4.5	6.3	1.4	10.8	8.6	19.7	31.4	1.8	27.7	6.9	4.9	25.0	4.9	52.1	14.7	7.7	4.7	7.5	20.2	4.4	5.2	25.3	7.2	17.1	13.9	0.9	2.7	6.6	18.8	3.5	9.4	8.5	13.2	4.2	2.0	17.6	29.5	3.4	16.8	9.9	5.3	3.5	21.8	0.9	4.1	10.7	8.5	4.3	11.5	0.1	0.9	10.2	2.6	3.0	4.1	0.8	2.3	3.7	1.9	0.7	6.0	6.8	4.1	1.2	5.3	1.9	2.3	0.5	3.4	0.0	9.5	0.5	13.1	7.9	0.3	1.0	3.0	1.9	1.6	2.2	5.9	13.2	2.7	3.8	10.5	2.6	5.8	2.2	1.1	5.4	30.3	0.6	1.4	0.0	0.4	0.6	0.0	3.2	0.4	6.0	2.7	0.1	0.8	0.0	4.7	0.9	0.0	0.0	4.1	2.5	16.9	2.8	4.7	5.0	26.3	0.8	3.2	2.1	1.3	5.1	4.1	0.0	3.7	4.6	1.0	10.2	2.6	3.2	0.5	1.6	4.1	0.0	0.4	1.0	0.9	0.1	0.0	0.1	1.5	3.0	0.5	0.0	1.2	0.8	5.3	20.4	1.4	10.8	7.7	4.7	25.3	7.2	18.8	21.8	0.0	6.6	1.3	2.8	6.4	0.2	30.1	50.9	5.3	7.9	1.8	0.0	2.4	3.3	5.9	7.9	5.4	31.5	0.0	3.0	3.0	6.6	0.7	27.6	13.1	16.2	0.0	4.1	3.7	11.7	6.1	9.8	3.8	11.8	1.8	21.0	0.0	2.0	14.4	4.2	44.6	0.0	19.4	2.0	5.4	3.6	30.6	1.9	4.5	12.7	4.3
PLD2		ENSG00000129219	"Phospholipase D2"	O14939	17	4807096-4823434	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013397	Approved					NA	NA					"HPA013397: AB_1855328"	"unprognostic (1.87e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.48e-2)"	9.9	6.4	9.0	8.2	10.4	2.0	11.0	14.6	10.8	14.9	7.6	18.1	13.4	6.1	11.2	11.7	36.2	13.0	12.3	7.2	10.5	7.8	7.2	6.9	11.7	7.5	10.0	7.0	14.9	12.6	11.4	6.5	14.6	12.2	11.0	8.1	9.8	13.7	26.7	4.3	27.8	6.1	11.8	8.9	7.8	7.0	3.5	13.2	7.3	7.3	20.0	16.8	10.6	20.6	2.6	5.3	4.1	7.4	1.1	3.1	2.9	7.5	12.0	10.8	11.3	9.3	12.5	12.2	5.0	10.4	8.7	7.0	12.7	9.0	3.3	5.8	12.7	3.2	17.5	8.3	10.9	8.1	4.2	4.1	1.1	8.9	7.8	6.8	0.0	8.3	18.3	16.6	7.8	7.1	12.4	20.0	2.3	1.2	3.1	6.7	5.7	0.4	1.4	5.6	6.3	5.2	3.6	6.8	0.8	7.9	12.9	3.5	6.3	9.2	10.9	6.8	9.5	7.8	1.8	15.6	5.7	5.8	12.8	7.6	2.9	1.3	0.7	8.8	1.5	3.3	4.1	6.9	1.6	2.0	7.4	1.5	2.6	2.0	1.5	5.3	1.5	0.6	0.7	0.5	1.1	7.2	2.3	3.1	2.9	9.0	10.4	14.6	10.8	10.5	7.8	10.0	7.0	12.2	13.2	0.0	0.6	1.4	8.3	11.2	1.4	1.2	7.6	5.3	4.5	1.8	0.0	18.5	1.7	8.3	0.0	8.8	4.7	0.0	10.0	12.3	6.0	9.6	5.7	2.4	11.9	0.0	1.2	8.6	5.7	0.0	8.9	9.9	6.8	29.7	5.9	7.1	7.9	7.0	8.1	3.1	1.7	0.0	4.1	0.0	2.9	10.7	14.5	2.9	4.6	10.0
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 12.3"	"Cell type enhanced"	"Detected in some"	23	"Collecting duct cells: 1.8;Early spermatids: 3.5;Spermatocytes: 9.3;Spermatogonia: 2.5"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 10.1;Karpas-707: 2.9"									HPA068342			Approved	"Endoplasmic reticulum,Cytosol"		NA	NA			Cytosol	"Endoplasmic reticulum"	"HPA068342: AB_2685976"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.0	0.1	0.4	0.2	1.0	0.0	0.1	0.7	0.8	0.0	0.1			0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.4		0.0	0.0	0.0	0.1	0.1		0.0	0.1		0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	12.3			0.0		0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	10.1	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	2.9	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	9.3	2.5	0.1	0.1	0.0	0.0	0.0
